(CIDRAP News) – Three new cases yesterday, with two deaths, increased a cluster of novel coronavirus (nCoV) cases in eastern Saudi Arabia to 13, and authorities confirmed that the illnesses are associated with a healthcare facility.
Saudi Arabian officials and the World Health Organization (WHO) reported three more novel coronavirus (nCoV) cases today in the same area of Saudi Arabia as seven cases reported yesterday, raising worries about possible person-to-person transmission.
(CIDRAP News) Questions abounded today concerning the large and growing outbreak of Escherichia coli infections concentrated in northern Germany, including where it came from, why it is striking mostly women, and why the number of reported hemolytic uremic syndrome (HUS) cases, at 276, is so unusually high.
(CIDRAP News) A new report says that a cell culture derived influenza vaccine and a conventional egg-based vaccine both proved effective in a large international clinical trial, offering support for those who contend that cell-based vaccines should become an important part of flu vaccine supplies in coming years.
(CIDRAP News) Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.
(CIDRAP News) After delaying action for weeks as the novel H1N1 influenza virus took hold in far-flung parts of the globe, the World Health Organization (WHO) today declared a full-fledged pandemic, formally recognizing that the virus is becoming a global contagion.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.